Senti Biosciences (SNTI) Misses Q1 EPS by 14c

Senti Biosciences (NASDAQ: SNTI) reported Q1 EPS of ($0.14). Revenue for the quarter came in at $10 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Senti Biosciences (SNTI) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Parsons wins $665M Army contract for support services
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance